119 related articles for article (PubMed ID: 8217787)
1. Bone marrow transplantation for myelodysplastic syndrome and secondary leukaemias.
De Witte T; Gratwohl A
Br J Haematol; 1993 Jul; 84(3):361-4. PubMed ID: 8217787
[No Abstract] [Full Text] [Related]
2. Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation.
Giralt S; Escudier S; Kantarjian H; Deisseroth A; Freireich EJ; Andersson BS; O'Brien S; Andreeff M; Fisher H; Cork A
N Engl J Med; 1993 Sep; 329(11):757-61. PubMed ID: 7688862
[TBL] [Abstract][Full Text] [Related]
3. Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome.
Alyea EP; Kim HT; Ho V; Cutler C; DeAngelo DJ; Stone R; Ritz J; Antin JH; Soiffer RJ
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1047-55. PubMed ID: 17067911
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome.
Bandini G; Rosti G; Calori E; Albertazzi L; Tura S
Br J Haematol; 1990 Jul; 75(3):442-4. PubMed ID: 2248673
[No Abstract] [Full Text] [Related]
5. Outcome after allogeneic bone marrow transplantation in cytogenetic high-risk myelodysplastic syndromes and acute myeloid leukemia.
Della Porta MG; Malcovati L
Haematologica; 2005 Oct; 90(10):1298C. PubMed ID: 16219554
[No Abstract] [Full Text] [Related]
6. Prognostic variables in bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes: a survey of the working party on leukaemia.
de Witte T; Hermans J; van Biezen A; Vernant J; Kolb H; Zwaan F; Vossen J; Lönnqvist B; Beelen D; Ferrant A
Bone Marrow Transplant; 1991; 7 Suppl 2():40. PubMed ID: 1878713
[No Abstract] [Full Text] [Related]
7. Bone marrow transplantation for myelodysplastic syndrome and secondary leukemia: outcome of 86 patients.
Sutton L; Leblond V; Le Maignan C; Jouet JP; Kuentz M; Gluckman E; Blaise D; Marit G; Attal M; Troussard X
Bone Marrow Transplant; 1991; 7 Suppl 2():39. PubMed ID: 1878712
[No Abstract] [Full Text] [Related]
8. Allogeneic bone marrow transplantation in high-risk myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC).
Ratanatharathorn V; Karanes C; Lum LG; Uberti J; Dan ME; de Planque MM; Schultz KR; Cronin S; Leisz MC; Mohamed A
Bone Marrow Transplant; 1992 Jan; 9(1):49-55. PubMed ID: 1543949
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplants for patients with acute leukemia and myelodysplastic syndrome using unrelated donors.
Messner HA
Transfus Sci; 1991; 12(3):151-3. PubMed ID: 10149544
[No Abstract] [Full Text] [Related]
10. Chromosomal studies after bone marrow transplantation for leukaemia in children.
van den Berg H; Beverstock G; Westerhof JP; Vossen JM
Bone Marrow Transplant; 1991 May; 7(5):335-42. PubMed ID: 2070142
[TBL] [Abstract][Full Text] [Related]
11. Timing of marrow transplantation in secondary leukemias and myelodysplastic syndromes.
De Witte T; Zwaan F; Gratwohl A; Vernant J; Kolb HJ; Vossen J; Lonnqvist B; Beelen D; Ferrant A; Gmür J
Transplant Proc; 1989 Feb; 21(1 Pt 3):2958-9. PubMed ID: 2650404
[No Abstract] [Full Text] [Related]
12. Unrelated cord blood transplantation for adult patients with myelodysplastic syndrome-related secondary acute myeloid leukaemia.
Ooi J; Iseki T; Nagayama H; Tomonari A; Ito K; Shirafuji N; Tojo A; Tani K; Asano S
Br J Haematol; 2001 Sep; 114(4):834-6. PubMed ID: 11564071
[TBL] [Abstract][Full Text] [Related]
13. [Bone marrow transplantation for myelodysplastic syndrome].
Sobue R; Hirano M
Nihon Rinsho; 1990 Sep; 48(9):2092-5. PubMed ID: 2232215
[No Abstract] [Full Text] [Related]
14. No increase in relapse in patients with myeloid leukaemias receiving rhGM-CSF after allogeneic bone marrow transplantation.
Gupta P; Tiley C; Powles R; Treleaven J; Millar J; Catalano J
Bone Marrow Transplant; 1992 Jun; 9(6):491-3. PubMed ID: 1628135
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic stem cell transplantation in patients with myelodysplastic syndrome: outcome analysis according to the International Prognostic Scoring System.
Rubio S; Martins C; Lacerda JF; Carmo JA; Lourenço F; Lacerda JM
Acta Med Port; 2006; 19(5):343-7. PubMed ID: 17376319
[TBL] [Abstract][Full Text] [Related]
16. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study.
Woods WG; Kobrinsky N; Buckley J; Neudorf S; Sanders J; Miller L; Barnard D; Benjamin D; DeSwarte J; Kalousek D
J Clin Oncol; 1993 Aug; 11(8):1448-57. PubMed ID: 8336184
[TBL] [Abstract][Full Text] [Related]
17. Therapy-related myelodysplastic syndrome and acute myeloid leukemia after autologous bone marrow transplantation: dosis facit venenum?
Sill H; Olipitz W; Schimek MG
J Clin Oncol; 2005 Nov; 23(31):8120-1; author reply 8121-2. PubMed ID: 16258113
[No Abstract] [Full Text] [Related]
18. Bone marrow transplantation from unrelated donor in myelodysplastic syndromes.
Alessandrino EP; Bernasconi P; Bonfichi M; Caldera D; Campagnoli C; Boni M; Bernasconi C
Bone Marrow Transplant; 1993; 11 Suppl 1():71-3. PubMed ID: 8448554
[No Abstract] [Full Text] [Related]
19. Effective graft-versus-leukaemia effect after allogeneic stem cell transplantation using reduced-intensity preparative regimens in Fanconi anaemia patients with myelodysplastic syndrome or acute myeloid leukaemia.
Guardiola P; Kurre P; Vlad A; Cayuela JM; Espérou H; Devergie A; Ribaud P; Socié G; Richard P; Traineau R; Storb R; Gluckman E
Br J Haematol; 2003 Sep; 122(5):806-9. PubMed ID: 12930393
[TBL] [Abstract][Full Text] [Related]
20. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
